Top Markets
#1 Siacoin Siacoin +12.95%
#2 Cash Cat Cash Cat +10.66%
#3 0G 0G +8.47%
#4 Arbitrum Arbitrum +6.98%
#5 MarsCoin MarsCoin +6.72%
#6 Seeker Seeker +6.47%
#7 Metis Metis +5.66%
#8 Useless Coin Useless Coin +4.46%
#9 UnifAI Network UnifAI Network +4.42%
#10 Story Story +4.27%
Coin of the day
Siacoin Siacoin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Classement en actions #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Prix de l'action
$0.88012714
Dernière synchronisation: 2026-08-31
Capitalisation boursière
$439.58M
Changement (1 jour)
-4.01%
Changement (1 an)
1,131.97%
Pays
FR
Échange Valerio Therapeutics S.A. (ALVIO)

Catégorie

Healthcare
Ratio P/B pour Valerio Therapeutics S.A. (ALVIO)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Valerio Therapeutics S.A., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Valerio Therapeutics S.A. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH